CTCF and Cognitive impairment: These downregulated pathways elucidate the phenotypes of small size, stem cell depletion, and abnormal neurodevelopment in the mutant organoids, consistent with the clinical manifestations of growth retardation and intellectual impairment in heterozygous CTCF mutant cases.